Clinical Trial: Chaigui Jieyu Qufa Decoction for CRF in Driver Gene-negative Lung Adenocarcinoma Trial

U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07890051) titled 'Chaigui Jieyu Qufa Decoction for CRF in Driver Gene-negative Lung Adenocarcinoma Trial' on Oct. 16.

Brief Summary: The goal of this [clinical trial] is to [evaluate whether Chaiyu Jieyu Qufa Decoction can improve cancer-related fatigue and assess its safety] in [patients aged 18-80 years with untreated lung adenocarcinoma complicated with cancer-related fatigue of liver depression and spleen deficiency syndrome, who are scheduled to receive first-line platinum plus pemetrexed combined with PD-1/PD-L1 therapy]. The main question[s] it aims to answer [is/are]:

[Does Chaiyu Jieyu Qufa Decoction reduce the severity of cancer-related fa...